FDA Explores Wearables and Apps in Clinical Drug Trials
Published Date: 3/31/2026
Notice
Summary
The FDA wants to hear from drug and biotech companies about using digital health tools, like wearable devices and apps, in clinical trials. They’re exploring ways to make these technologies easier and safer to use, which could speed up drug development and improve patient care. If you’re involved in drug research, now’s the time to share your thoughts before June 1, 2026!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in